About the Company
We do not have any company description for Check-Cap Ltd at the moment.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest News on Check-Cap Ltd
CHEK Stock Quote Price and Forecast | CNN
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Its patented technology, C ...
Check-Cap Ltd.: 6 Things for Potential CHEK Stock Investors to Know ...
Check-Cap Ltd. (NASDAQ:CHEK) stock is on the rise Monday despite a lack of news concerning the company. Shares of CHEK stock are skyrocketing alongside heavy trading. As of this writing, more than ...
Why Check-Cap Shares Are Trading Higher By Over 52%; Here Are 20 Stocks ...
Shares of Check-Cap Ltd CHEK rose sharply in today's pre-market trading after the company announced it was granted European Patent Number EP4087488 titled “RADIATION CAPSULE FOR BOWEL DISEASE ...
Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business ...
Nobul AI Corp and Check-Cap Ltd Enter into Definitive Business Combination Agreement Mar. 25, 2024 7:15 PM ET Check-Cap Ltd. (CHEK) ...
Check-Cap Ltd. Announces $35 Million Registered Direct Offering
ISFIYA, Israel, June 30, 2021 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the ...
Check-Cap Ltd. Company & People | CHEK | Barron's
Check-Cap Ltd. is a clinical stage medical diagnostics company, which engages in the development of ingestible imaging capsule systems for colorectal cancer screening. Its patented technology, C ...
Check-Cap Ltd. Reports Financial Results for First Half of 2024
Check-Cap Ltd. reported its financial results for the six months ending June 30, 2024, highlighting a decrease in total assets from $25,017,000 in December 2023 to $18,090,000.
Check-Cap Ltd. (CHEK) Upgraded to Buy: What Does It Mean for ... - Nasdaq
The upgrade of Check-Cap Ltd. to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move higher in the near term.
Check-Cap Receives FDA IDE Approval for Pivotal Study of C-Scan(R)
ISFIYA, Israel, March 15, 2021 /PRNewswire/ — Check-Cap Ltd. (the “Company” or “Check-Cap”) (NASDAQ: CHEK), (NASDAQ: CHEKZ), a clinical stage medical diagnostics company advancing the ...
Check-Cap Ltd. Announces $35 Million Registered Direct Offering
Full exercise of the warrants would generate additional gross proceeds of approximately $38.9 million to Check-Cap, less placement agent’s fees, if any.
Similar Companies
| Company | Ticker | 90 Days Forecast | Market Cap. (USD M) | P/E | P/B |
|---|---|---|---|---|---|
| Butterfly Network, Inc. | BFLY | Predict | 0.00 | -7.88 | 0.00 |
| Check-Cap Ltd | CHEK | Predict | 3.89 | None | 0.13 |
| GE HealthCare Technologies Inc. | GEHC | Predict | 34523.15 | 15.41 | 3.56 |
| HOLOGIC INC | HOLX | Predict | 0.00 | 24.09 | 0.00 |
Loading the latest forecasts...